Mechanism of Tamoxifen's Retinal Toxicity, Studied in Pig Pigment Epithelial Cell Cultures

Alternatives to Laboratory Animals

Volumn 25, Issue 3, 1997, Pages 297-302

  Mäenpää, Hanna ^a   Toimela, Tarja ^a   Saransaari, Pirjo ^a   Salminen, Lotta ^b   Tähti, Hanna ^a  

^a UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Epithelium; Eye toxicity; Glutamate uptake; Retinal pigment; Tamoxifen

Indexed keywords

SUS SCROFA;

EID: 0000928904     PISSN: 02611929     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Pavlidis, N.A., Petris, C , Briassoulis, E., Klouvas, G., Psilas, C , Rampapis, J & Petroutsos, G, (1992) Clear evidence that long-term, low-dose tamoxifen treatment can induce ocular toxicity; a prospective study of 63 patients Cancer 69, 2961-2964.
2. Chern, S & Danis, R P (1993) Retinopathy associated with low-dose tamoxifen American Journal of Ophthalmology 116, 372-373
3. Nayfield, S G. & Gorin, M.B (1996). Tamoxifenassociated eye disease a review Journal of Clinical Oncology 14, 1018-1026.
4. Pautler, E L & Tegerly, C (1986) Transport of acidic amino acids by the bovine pigment epithelium Experimental Eve Research 43, 207-214
5. Törnquist, P., Alm, A. & Bill, A (1990) Permeability of ocular vessels and transport across the blood-retinal barrier. Eve 4, 303-309.
6. Berman, E R (1991). Retina In Biochemistry of the Eye: Perspectives in Vision Research (ed C. Blakemore), pp 380-381. New York: Plenum Press.
7. +-dependent glutamate transport in human retinal pigment epithelial cells. Investigative Ophthalmology and Visual Science 35, 3589-3598.
8. Olney, J W (1982). The toxic effects of glutamate and related compounds in the retina and the brain Retina 2, 341-359
9. Choi, D W , Koh, J & Peters, S (1988) Glutamate neurotoxicity and diseases of the nervous system Neuron. 1, 623-634
10. Toimela, T , Tahti, H & Salminen, L. (1995) Retinal pigment epithelium cell culture as a model for evaluation of the toxicity of tamoxifen and chloroquine Ophthalmic Research 27, 150-153
11. Lowry, O H , Rosebrough, N J., Farr, A L & Randall, R.J. (1995) Protein measurement with the folin phenol reagent Journal of Biological Chemistry 193, 265-275
12. Lien. E A , Solheim, E , Lea. O A , Lungren, S., Kvinnsland, S & Ueland, P M (1989) Distribution of 4-hydroxytamoxifen and other tamoxifen metabolites in human biological fluids during tamoxifen treatment Cancer Research 49, 2175-2183
13. Stuart, N S , Philip, P . Harris, A L , Tonkin, K , Houlbrook, S , Kirk. J , Lien, E A & Carmichael, J (1992) High-dose tamoxifen as an enhancer of epoxide cytotoxicity clinical effects and in vitro assessment in P-glycoprotein expressing cell lines British Journal of Cancer 66, 833-839.
14. Lien, E.A , Solheim, E & Ueland, P.M (1991) Distribution of tamoxifen and its metabolites in rat and human tissues during steady-state treatment Cancer Research 51, 4837-4844
15. Robinson, S P , Langan-Fahey, S.M., Johnson, D A & Jordan, V C (1991) Metabolites, pharmacodynamics and pharmacokinetics of tamoxifen in rats and mice compared to breast cancer patients Drug Metabolism and Disposition 19, 36-43.
16. Monaghan, D.T . Bridges, R.J. & Cotman. C W. (1989) The excitatory amino acid receptors their classes, pharmacology and distinct properties in the function of the central nervous system. Annual Review of Pharmacology and Toxicology 29, 365-402
17. 2-: toxicity is blocked by the N-methyl-D-aspartate antagonist MK-801 Proceedings of the National Academy of Sciences USA 85, 6556-6560
18. Salceda, R & Saldana, M R. (1993). Glutamate and taurine uptake by retinal pigment epithelium during rat development. Comparative Biochemistry and Physiology 104. 311-316.
19. Jordan, V C (1984). Biochemical pharmacology of antiestrogen action. Pharmacological Reviews 36, 245-276.
20. Ramkumar, T & Adler, S. (1995). Differential positive and negative transcriptional regulation by tamoxifen Endocrinology 136, 536-542.
21. 3H]-tamoxifen to the 8S estradiol receptor. Molecular and Cellular Endocrinology 11, 181-198.
22. Borras, M , Jin, L , Bouhoute, A., Legros, N. & Leclereq, G (1994) Evaluation of estrogen receptor, antiestrogen binding sites and calmodulin for antiestrogen resistance of two clones derived from the MCF-7 breast cancer cell line Biochemical Pharmacology 48, 2015-2024.
23. Charlier, C , Chariot, A , Antoine, N., Merville, M P , Gielen, J & Castronovo, V (1995) Tamoxifen and its active metabolite inhibit growth of estrogen receptor-negative mda-mb-435 cells. Biochemical Pharmacology 49, 351-358
24. Beato, M (1989) Gene regulation by steroid hormones Cell 56, 335-344.
25. Jordan, V C (1994). Molecular mechanisms of antiestrogen action in breast cancer Breast Cancer Research and Treatment 31, 41-52.
26. Costa, L. (1990) The phosphoinositide/protein kinase C system as a potential target for neurotoxicity. Pharmacological Research 22, 393-408.
27. Bignon, E., Pons, M., Doré, J.C., Gilbert, J., Ojasoo. Y., Miquel, J.F., Raynaud, J.P. & Crastes de Paulet, A. (1991). Influence of di- and tri-phenylethylene estrogen/antiestrogen structure on the mechanisms of protein kinase C inhibition and activation as revealed by a multivariate analysis. Biochemical Pharmacology 42, 1373-1383.
28. Casado, M , Bendahan, A., Zafra, F., Danbolt, N.C., Aragon, C , Giménez, C. & Kanner, B.I. (1993), Phosphorylation and modulation of brain glutamate transporters by protein kinase C. Journal of Biological Chemistry 268, 27,313-27,317.
29. O'Brian, C.A., Liskamp, R.M., Solomon, D.H. & Weinstein, I.B. (1985). Inhibition of protein kinase C by tamoxifen. Cancer Research 45, 2462-2465.
30. Horgan, K., Cooke, E., Hallett, M.B. & Mansel, R.E. (1986). Inhibition of protein kinase C mediated signal transduction by tamoxifen. Biochemical Pharmacology 35, 4463-4465.
31. 2 by transforming growth factor-α in HEL-30 keratinocytes. Journal of Biological Chemistry 268, 16, 795-16,802.
32. Sheu, S.J , Sakamoto, T , Osusky, R., Wang, H.M., Ogden, T.E., Ryan, S J., Hinton, D.R. & Gopalakrishna, R.A.D. (1994). Transforming growth factor-β regulates human retinal pigment epithelial cell phagocytosis by influencing a protein kinase C-dependent pathway. Graefes Archive for Clinical and Experimental Ophthalmology 232, 695-701